baber/WOPTO huggingface dataset:
Patent AU-5485594-A (AU)
Title: Preparation of carbonic anhydrase inhibitors
Inventor: DEAN WILLIAM D
IPC: C07D513/04
Filed: 1994-02-01
Abstract: Carbonic anhydrase inhibitors, useful in the control of ocular hypertension, and having the formula: <CHEM> wherein: R1 and R2 are both chosen from H or C1-4 alkyl; R3 = C1-6 alkyl or CH2(CH2)nOR4 where R4=CH3 or (CH2)nCH3 and n = 1-4; or (CH2)nAr where Ar = unsubstituted phenyl, 3-methoxyphenyl, or 4-methoxyphenyl and n = 1 or 2. are prepared by displacing the C(2)-chloro of 3-acetyl- 2,5-dichlorothiophene with benzyl mercaptide to form the thioether of structure, which is then converted to 3-acetyl-5-chloro-2-thiophenesulfonamide by reaction with chlorine to form 3-acetyl-5-chloro-2-thiophenesulfenyl chloride, followed by reaction with ammonia to form 3-acetyl-5-chloro-2-thiophenesulfenamide, and finally oxidation. Bromination provides 3-bromoacetyl-5-chloro- 2-thiophenesulfonamide which is converted to (S)-3,4- dihydro-6-chloro-4-hydroxy-2H-thieno[3,2-e]-1,2-thiazine-1,1-dioxide by reduction with (+)- beta -chlorodisopinocampheylborane followed by treatment with aqueous base. Alkylation at N(2) provides the (S)-3,4-dihydro-6-chloro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2- thiazine-1, 1-dioxide. Formation of the C(6) anion is accomplished by halogen-metal exchange, and the anion is reacted with sulfur dioxide to form a lithium sulfinate, which upon reaction with hydroxylamine-O-sulfonic acid provides the (S)-3,4-dihydro-4-hydroxy-2-substituted-2H-thieno[3,2-e]-1,2-thiazine- 6-sulfonamide-1, 1-dioxide. Protection of the C(6)-sulfonamide functionality, followed by activation of the C(4)-hydroxyl and displacement with an appropriate amine provides the (R)-3,4-dihydro-4-alkylamino-2-substituted-2H-thieno[3,2-e]-1,2-thiazi ne-6-sulfonamide-1,1-dioxide.
Patent AU-5487090-A (AU)
Title: Method and apparatus for the direct transfer of information between application programs running on distinct processors without utilizing the services of one or both operating systems
IPC: G06F9/46
Filed: 1990-05-09
Abstract: The functions of two virtual opening systems (e.g. S/370 VM, VSE or IX370 and S/88 OS) are merged into one physical system. Partner pairs of S/88 processors run the S/88 OS and handle the fault tolerant and single system image aspects of the system. One or more partner pairs of S/370 processors are coupled to corresponding S/88 processors directly and through the S/88 bus. Each S/370 processor is allocated form 1 to 16 megabytes of contiguous storage from the S/88 main storage. Each S/370 virtual operating system thinks its memory allocation starts at address 0, and it manages its memory through normal S/370 dynamic memory allocation and paging techniques. The S/370 is limit checked to prevent the S/370 from accessing S/88 memory space. The S/88 Operating System is the master over all system hardware and I/O devices. The S/88 processors across the S/370 address space in direct response to a S/88 application program so that the S/88 may move I/O data into the S/370 I/O buffers and process the S/370 I/O operations. The S/88 and S/370 peer processor pairs to execute their respective Operating Systems in a single system environment without significant rewriting of either operating system. Neither operating system is aware of the other operating system nor the other processor pairs.
Patent AU-5653386-A (AU)
Title: A beverage dispensing system
Inventor: HEDDERICK JOHN BARCLAY
IPC: B67D1/14
Filed: 1986-04-23
Abstract: @ A beverage dispensing system has a valve in a tap 6 controlling dispensing of the beverage through a passage 5 from a rigid or flexible container. Air, nitrogen (or other inert gas) or carbon dioxide gas from a passage 15 is introduced into the beverage in the passage 5 during dispensing for development of a head or froth. The introduced gas flows under pressure (which is preferably adjustable) from the passage 15 and by way of a capilliary tube restrictor 18 and a non return valve 21 communicating with the tube 18 into the beverage in passage 5. The non return valve 21 has a resilient diaphragm 27 which normally closes that valve and is displaceable under gas pressure to admit the gas to the beverage. A labyrinthine mixer 39 is located in the passage 5 downstream of the position where the gas is introduced.
Patent AU-5676094-A (AU)
Title: Temperature controller outlet
Inventor: STOUFFER RONALD D
IPC: B60H1/24
Filed: 1993-11-30
Abstract: Control of temperature of air efflux from an air outlet is by control of the oscillation of a fluidic oscillator. Directionality of efflux is by control of nibs at the outlet.
Patent AU-5689298-A (AU)
Title: An electricity generating system having an annular combustor
Inventor: TEETS J MICHAEL
IPC: F23K5/14
Filed: 1997-12-03
Abstract: An electricity generating system having a body (159), an annular combustor (14), a turbine (16), a compressor chamber and a compressor (102) positioned within the compressor chamber. An inlet port is in fluid communication with the compressor chamber and an exit port is in fluid communication with the turbine. A plurality of magnets (MG) is secured to the rotor (18) and a stator (22) made of mangnetically attracted material, such as iron, and having a stator winding provided in the body (159). The stator winding is positioned in close proximity to the plurality of magnets mounted to the rotor whereby rotation of the rotor (18) induces a current in the winding.
Patent AU-5717301-A (AU)
Title: Apo-ai/aii peptide derivatives
Inventor: KOHNO TADAHIKO
IPC: A61P3/00
Filed: 2001-04-23
Abstract: The present invention concerns therapeutic agents that mimic the activity of Apo-AI amphipathic helix peptide. In accordance with the present invention, the compounds of the invention comprise: a. a Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domain, preferably the amino acid sequence of SEQ ID NO: 7, or sequences derived therefrom by phage display, RNA-peptide screening, or the other techniques mentioned above; and b. a vehicle, such as a polymer (e.g., PEG or dextran) or an Fc domain, which is preferred; wherein the vehicle, preferably an Fc domain, is covalently attached to the Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domain. The vehicle and the Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domain may be linked through the N- or C-terminus of the Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domain, as described further below. The preferred vehicle is an Fc domain, and the preferred Fc domain is an IgG Fc domain. Preferred Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domains comprise the amino acid sequences described in Table 1. Other Apo-AI amphipathic helix peptide or Apo-AI amphipathic helix peptide-mimetic domains can be generated by phage display, RNA-peptide screening and the other techniques mentioned herein.
Patent AU-5740099-A (AU)
Title: Method for testing the toxicity of chemical substances using gastropods
Inventor: REMON JEAN PAUL
IPC: G01N33/50
Filed: 1999-08-24
Abstract: An in vivo and an in vitro toxicity test method is described using an organisim or part of an organism from the class Gastropoda. The method is particularly useful for toxicity testing of chemical substances intended for application to human or animal mucosa, such as the intestinal, vaginal, buccal, nasal or respiratory mucosa. The test method may be used both as a screening test and also as a quantitative toxicity test suitable for ranking the toxicity of chemical substances.
Patent AU-5741499-A (AU)
Title: Polymeric films
Inventor: BIDDISCOMBE HELEN
IPC: G09F3/04
Filed: 1999-08-26
Abstract: In-mold labelled, blow-molded articles formed from high density polyethylene, the labels being formed from biaxially oriented polypropylene based films having a shrinkage of at least 4% in both the machine and transverse directions as measured by the OPMA shrink test in which the film is suspended in an oven at 130° C. for a period of 10 minutes. The use of films with the specified shrinkage enables blistering and "orange peel" effects to be avoided when the blow-molding is carried out.
Patent AU-5818294-A (AU)
Title: Multilayer duct and die for producing same
Inventor: LEROY JEAN-MARIE
IPC: B29C48/09
Filed: 1993-12-28
Abstract: PCT No. PCT/FR93/01311 Sec. 371 Date Aug. 22, 1995 Sec. 102(e) Date Aug. 22, 1995 PCT Filed Dec. 28, 1993 PCT Pub. No. WO94/15130 PCT Pub. Date Jul. 7, 1994A multilayer pipe is comprised of an internal tubular ply made from a synthetic material, a strengthening reinforcement member also made from a synthetic material and an external ply made from a synthetic material. At least one of the plies is bonded, by melting, to the reinforcement member. The strengthening reinforcement member has, over the whole or part of its length, a reticulate lacunary structure, of which only internal and external faces thereof are bonded to corresponding adjacent plies. Spaces of the lacunary structure are blocked off by, but not filled by, these plies.
Patent AU-5899400-A (AU)
Title: Ant controllers and method for application thereof
Inventor: TAKAGI KAZUHIRO
IPC: A01N37/44
Filed: 2000-06-28
Abstract: The present invention provides an excellent ant controller for protecting wooden materials such as trees, board fences, sleepers, etc. and structures such as shrines, temples, houses, outhouses, factories, etc. from termites, and for controlling ants doing harm to crops or humans, which contains as active ingredient thereof a hydrazine derivative represented by general formula (I) [wherein A represents one of formulas (II), (III), (IV), and (V), (wherein R4 and R5 are H, C1-C6 alkyl, etc.; X is 1 to 5 substituents selected from H, halogen and (halo) C1-C6 alkyl); R1 is H or C1-C6 alkyl; R2 and R3 are H, OH, C1-C6 alkyl, phenylcarbonyl, etc.; Y is 1 to 5 substituents selected from H, halogen, nitro and cyano; Z is halogen, cyano, C1-C6 alkyl, etc.; and W is O or S]; and a method for application of the ant controller.
Patent AU-5978999-A (AU)
Title: Self-closing valve arrangement for the dispensing opening of a container
Inventor: ALBERS MARTIN
IPC: B65D47/20
Filed: 1999-09-16
Abstract: A self-closing valve assembly for installation in a dispensing opening of a container, a seal cap or the like, includes a first closure element having a domed wall portion of resilient material incorporating a passage-opening, said wall portion being resiliently deformable from a closed position into an open position under the influence of a first differential pressure force resulting from pressures acting on its opposite surfaces, and a second closure element having a domed wall portion for sealing the passage-opening when the first closure element is in its closed position. In order to balance the pressure prvailing in a container provided with the valve assembly when a pressure-increasing squeezing force is no longer exerted on the container, the second closure element is adapted to be brought out of its sealing relationship with the passage-opening in the first closure element under the influence of a second differential pressure force resulting from pressures acting on its opposite surfaces, said second differential pressure force being directed oppositely to said first differential pressure force.
Patent AU-6108698-A (AU)
Title: In vitro peptide or protein expression library
Inventor: LINDQVIST BJORN H
IPC: C12N15/09
Filed: 1998-02-18
Abstract: The present invention relates to methods of producing peptide or protein expression libraries. In such a library, a population of nucleotide sequences is expressed. The resulting peptides or proteins encoded by those nucleotide sequences are then screened to identify those peptides or proteins having a desired property such as the ability to bind a selected ligand. In the construction and screening of such libraries, it is desired to ensure that the nucleotide encoding a particular protein remains connected in some way with that protein so that once a desired protein having a selected property has been isolated, its encoding nucleotide sequence may be specifically recovered for subsequent manipulation for example using PCR or sequencing. The present invention makes use of a property not previously described in constructing an expression library namely the use of proteins which covalently bind DNA. DNA is expressed in such a way that the protein so expressed binds to its own encoding DNA therefore allowing the DNA to be associated only with its encoding protein.
Patent AU-6114798-A (AU)
Title: Method for pickling products of a metal alloy in absence of nitric and for recovering exhausted pickling solutions and apparatus therefore
Inventor: MANCIA FRANCO
IPC: C23G1/36
Filed: 1998-02-25
Abstract: A method for pickling products in a metal alloy containing iron, and products in titanium and alloys thereof, in the absence of nitric acid as an oxidizing agent, and for the recovery of the exhausted solutions, characterized in that the recovery of the exhausted solutions deriving from pickling comprises the following steps: sending of the pickling solution, both as catholyte and as anolyte, in an electro-chemical cell optionally of the membrane type to separate the Fe2+ (or Ti2+) ions to be disposed of, from the Fe3+ (or of the Ti3+ and Ti4+) ions to be recovered, obtained by reduction at the cathode of the Fe3+ ions which are in the catholyte to Fe2+ (or of the Ti3+ and Ti4+ ions to Ti2+) and of oxidation at the anode Fe2+ (or Ti2+) ions which are in the anolyte to Fe3+ (to Ti3+ and Ti4+); treating the catholytic solution coming out of the cell and enriched in Fe2+ (or Ti2+) ions as to allow the separation in two phases, a first phase containing the metal canions Fe2+, Cr3+, Ni2+ (or Ti2+) to be disposed of and a second liquid phase deprived of said metal cations to be sent in the pickling bath; and sending the anolytic solution, coming out of the cell and enriched in Fe3+ ions (or Ti3+ or Ti4+), in the pickling bath. It is also the object of the present invention an apparatus thereof.
Patent AU-6532400-A (AU)
Title: Silicone coated textile fabrics
Inventor: BUDDEN GRAHAM D
IPC: D06M15/643
Filed: 2000-08-09
Abstract: A curable silicone-based coating composition, curable to a flexible coating at a coat weight of up to 15 g/m2 when cured, comprises an organopolysiloxane polymer having at least two silicon-bonded olefinically unsaturated hydrocarbon substituents, alkoxy groups or hydroxyl groups and having a degree of polymerization of no more than 150, a cross-linking organosilicon material having at least 3 silicon-bonded reactive groups and a catalyst. The coating composition optionally contains non-reinforcing filler but contains no more than 3% by weight of reinforcing filler. The coating is preferably used on a textile fabric that has an elastomeric coating on it, and reduces friction. It is particularly useful for airbags.
Patent AU-6559901-A (AU)
Title: Elastically stretchable composite sheet and disposable wearing article using this composite sheet
Inventor: GODA HIROKI
IPC: A61F13/496
Filed: 2001-08-31
Abstract: An elastically stretchable sheet 1 used, for example, as stock material for front and rear waist regions includes an elastically stretchable first sheet 11, a third sheet 13 longer than said first sheet 11 and bonded to said first sheet 11 so as to form pleats, and a second sheet 12 longer than said first and third sheets 11, 13 and bonded directly or indirectly to said first sheet 11 so as to form pleats. <IMAGE>
Patent AU-6623401-A (AU)
Title: Methods of and apparatus for sealing zipper to a substrate
Inventor: LEIGHTON MURRAY EDWARD BRUCE
IPC: B31B19/90
Filed: 2001-07-05
Abstract: A reclosable fastener (10) comprising a two-part body and a single flange (16) is located between two webs (34) of material from which a bag is to be made on a form-fill-seal machine. The fastener is attached initially to the inside of one web (34) by the flange (16). The combination passes between sealing jaws (44) to seal the webs to the fastener at thickened zones (30) at the margins of the body By making the body compact, and by using sealing jaws (44) which are longer than the body, the webs (34) form around the ends of the fastener body.
Patent AU-6627500-A (AU)
Title: Eye shield assembly
Inventor: BONDY DENNIS MICHAEL
IPC: A42B1/18
Filed: 2000-08-09
Abstract: An eye shield assembly is provided for use in conjunction with a hat having a brim. The eye shield assembly includes a frame and a lens mounted to the frame. The opposite sides of the frame are pivotally secured to the hat brim so that the frame is movable between a storage position and an operational position. In its storage position, the lens nests closely adjacent to the brim while in the operational position, the lens depends generally perpendicularly downwardly from the brim.
Patent AU-6638894-A (AU)
Title: Fabricated articles made from ethylene polymer blends
Inventor: CHUM PAK WING STEVE
IPC: C08L23/04
Filed: 1994-04-19
Abstract: The disclosed ethylene polymer compositions have et least one homogeneously branched substantially linear ethylene/ alpha -olefin interpolymer and at least one heterogeneously branched ethylene polymer. The homogeneously branched linear or substantially linear ethylene/ alpha -olefin interpolymer has a density from about 0.88 to about 0.935 g/cm<3> and a slope of strain hardening coefficient greater than or equal to about 1.3. Films made from such formulated compositions have surprisingly good impact and tensile properties, and have an especially good combination of modulus and toughness.
Patent AU-6673100-A (AU)
Title: Topical antiseptic composition
Inventor: MESSIER PIERRE JEAN
IPC: A01N59/12
Filed: 2000-08-07
Abstract: A topical antiseptic composition comprising an antiseptic active agent and a dermatologically acceptable carrier for topical application, the antiseptic active agent comprising a halogenated resin.
Patent AU-6809294-A (AU)
Title: Homogeneous catalyst and process for liquid phase isomerization and alkylation
Inventor: SHERMAN LARRY G
IPC: C07C2/58
Filed: 1993-12-13
Abstract: A discrete catalyst and processes for the isomerization of alkanes and alkenes and the alkylation of isoalkanes with alkenes under homogeneous fluid conditions. The catalyst is formed by contacting, under fluid conditions, a homogeneous fluid containing a paraffin hydrocarbon having from 4 to 12 carbon atoms (106) with a Lewis acid/protic Bronsted acid pair (182) and, if desired, a transition metal to produce a discrete catalytic complex that is soluble in the fluid (113). The discrete catalyst is the reaction product of the acid pair and alkanes and includes hydrocarbon ligands of limited chain length rendering it soluble in the fluid. The catalyst is active for the isomerization of alkanes and olefins, and the alkylation of isoalkanes (116), under homogeneous fluid conditions.
Patent AU-6820594-A (AU)
Title: Independent photoelectric artificial retina device and method
Inventor: CHOW ALAN Y
IPC: A61F2/16
Filed: 1994-04-28
Abstract: Microscopic photodiode devices with semi-transparent surface electrodes are combined with a liquid or other suitable vehicle. Together they are injected into the subretinal space of the eye. The purpose of these microphotodiode photovoltaic devices is to transduce incident light into electric current which stimulate the overlying cellular layers of the retina. In persons suffering from visual dysfunction due to outer retinal layer damage, such devices may allow useful formed artificial vision. These independent surface electrode microphotodiodes (ISEMCPs) may be in the shape of micro-spheres, micro-cylinders or other micro-shapes. An off-center embedded ferromagnetic layer will confer magnetic susceptibility to the ISEMCPs. A magnetic field applied in the vicinity of the eye will align the ISEMCPs within the subretinal space directing their photoactive surface toward incident light. Alternatively ISEMCPs may be embedded, prealigned, in a transparent flexible sheet permeable to nutrients and oxygen before implantation into the subretinal space. Such a sheet will allow passage of biological nutrients and oxygen around the ISEMCPs. This sheet may also dissolve leaving behind ISEMCP units lying separately, or in an arranged pattern produced by a surrounding mesh. ISEMCPs may be of the PiN or NiP type or a combination of both in a single unit. An electric capacitor layer may also be incorporated into the ISEMCP device (ISEMCP-C) to allow charge storage during exposure to light and charge release in darkness producing an opposite polarity current. This last modification will allow the generation of hyperpolarizing currents in light and depolarizing currents in darkness which is necessary to produce formed vision of light and dark images.
Patent AU-7060987-A (AU)
Title: Process and apparatus for controlling the composition of a mixture leaving an evaporator
Inventor: LESCHKE RUDOLPH JOHANN
IPC: C13B25/06
Filed: 1987-03-25
Abstract: The composition of the final mixture leaving a two-stage evaporator is controlled by measuring the boiling temperature of the intermediate liquid mixture which leaves the first-stage and which is in equilibrium with the vapor stream leaving the first-stage. From this boiling temperature, the concentration of the less volatile component is calculated, and this calculated concentration is used to adjust the heat input to the second stage in order to produce a final product having a predetermined composition.
Patent AU-7063791-A (AU)
Title: Paging system employing designated frame commencing information service data message transmission
Inventor: SNOWDEN GREGORY O
IPC: H04B7/00
Filed: 1990-10-29
Abstract: A paging system which provides both individual and information services includes a transmitter which transmits page call address and data periodically in batches to subscribing paging receivers. Each batch comprising a synchronization code followed by a predetermined plurality of sequential frames. Each paging receiver searches for both its individual service address and a first information service address in its corresponding assigned frame of each batch of a transmission period, and in response to reception of the first information service address, searches for a second information service address in a designated common frame of each batch of a transmission period. Individual and information service data messages are obtained from frames immediately subsequent the frame in which the respective individual and second information service addresses are found.
Patent AU-7079300-A (AU)
Title: Compositions and methods for the treatment of immune related diseases
Inventor: GODDARD AUDREY
IPC: A61P7/06
Filed: 2000-08-23
Abstract: The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.